Australia (PRWEB) May 02, 2013
With heart disease being the top cause of death in the U.S., scientists have spent hundreds of thousands of hours and dollars trying to figure out how to lower this way too-high risk. Now it seems that L-carnitine, like that found in the popular weight loss supplement Liproxenol, may hold the key.
On April 11, 2013, the Mayo Clinic Proceedings published a study in which they reviewed 13 controlled trials to ascertain the importance of L-carnitine when it comes to death for all causes, arrhythmias and angina attacks. They took trials published on Ovid MEDLINE, PubMed and Excerpta Medica (Embase) between May 1st and August 31st, 2012 and studied them for their results.
What they found is that L-carnitine was connected to an overall reduction in mortality of 27%. Also, ventricular arrhythmias were reduced 65% and anginal symptoms in those who suffered from myocardial infarction, or a heart attack, went down 40%.
These findings cause them to believe that L-carnitine may, in fact, be a valid future cardiac treatment option. This suggests that Liproxenol, which is a popular weight loss supplement containing L-carnitine and other natural ingredients like green tea and cayenne powder, may just help fend off any potentially life threatening heart related issues.
About Liproxenol Nutraceuticals:
Liproxenol Nutraceuticals is recognized as an industry leader in the fields of health, wellness and better living. The company's products are enjoyed by customers around the world and are among a new class of supplements that are not only effective but also safe and made from 100% all-natural ingredients. Liproxenol Nutraceuticals is based in Australia and the USA.
Read the full story at http://www.prweb.com/releases/2013/5/prweb10648619.htm.
Copyright©2012 Vocus, Inc.
All rights reserved